The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy
Abstract Cancer is characterized as a complex disease caused by coordinated alterations of multiple signaling pathways. The Ras/RAF/MEK/ERK (MAPK) signaling is one of the best-defined pathways in cancer biology, and its hyperactivation is responsible for over 40% human cancer cases. To drive carcino...
Main Authors: | Jimin Yuan, Xiaoduo Dong, Jiajun Yap, Jiancheng Hu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | Journal of Hematology & Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13045-020-00949-4 |
Similar Items
-
The MEK/ERK Module Is Reprogrammed in Remodeling Adult Cardiomyocytes
by: Thomas Kubin, et al.
Published: (2020-09-01) -
ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells
by: Giulia Cesi, et al.
Published: (2017-06-01) -
Discovery of Raf Family Is a Milestone in Deciphering the Ras-Mediated Intracellular Signaling Pathway
by: Jingtong Zhao, et al.
Published: (2022-05-01) -
Ras/Raf/MEK/ERK pathway activation in childhood acute lymphoblastic leukemia and its therapeutic targeting
by: Thomas eKnight, et al.
Published: (2014-06-01) -
Targeting RAS–RAF–MEK–ERK signaling pathway in human cancer: Current status in clinical trials
by: Yanlin Song, et al.
Published: (2023-01-01)